PDCD1 and neoplasm: The initial multiple liver metastases in this 67-year-old patient could be a risk factor for HPD, or incomplete radiofrequency ablation could have promoted tumor progression and hindered the efficacy of anti-PD-1 therapy by inducing sustained local inflammation with predominant myeloid suppressor cells, which has been identified in clinical practice and mouse models (16).